Docebo Inc.
DCBO Nasdaq Services-Prepackaged Software Financials FY2019–FY2025
Last close · Oct 23, 2026
$30.91
1.3%What Docebo Inc. does
No business description yet.
- Legal name
- Docebo Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 40-F · Feb 27, 2026
- Accession · CIK
- 0001628280-26-012566
0001829959
Revenue and margins
Docebo Inc. had $243M of revenue in fiscal 2025, up 11.9% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $27.2M in fiscal 2025, 11.2% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Docebo Inc. returned — to shareholders in fiscal 2025. The diluted share count fell 5.2%.
Balance sheet
Cash, debt and the ratios that show how comfortably Docebo Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $215M | $216M | $72.0M | $92.5M | $74.0M |
| Debt incl. finance leases | $0.0M | — | — | — | — |
| Debt / equity | 0.0x | — | — | — | — |
| Current ratio | 3.6x | 3.1x | 1.3x | 1.2x | 1.2x |
| Quick ratio | 3.6x | 3.1x | 1.3x | 1.2x | 1.2x |
| Total assets | $268M | $284M | $158M | $191M | $207M |
| Total liabilities | $77.6M | $91.5M | $108M | $133M | $133M |
| Shareholders' equity | $191M | $192M | $50.7M | $57.8M | $74.1M |
| Net debt (− = net cash) | −$215M | — | — | — | — |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. “Plan” marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Net income is positive | ✕ | ✕ | ✕ | ✓ | ✓ | ✓ | ✓ |
| Cash from operations is positive | ✕ | ✓ | ✕ | ✓ | ✓ | ✓ | ✓ |
| Return on assets rose | — | ✓ | ✕ | ✓ | ✕ | ✓ | ✓ |
| Cash from operations exceeds net income | ✓ | ✓ | ✓ | ✕ | ✓ | ✓ | ✕ |
| Debt fell relative to assets | — | ✓ | ✓ | — | — | — | — |
| Current ratio rose | — | ✓ | ✕ | ✕ | ✕ | ✕ | ✓ |
| Share count didn't rise | — | ✕ | ✕ | ✕ | ✓ | ✓ | ✓ |
| Gross margin rose | — | ✓ | ✕ | ✓ | ✓ | ✓ | ✕ |
| Revenue rose relative to assets | — | ✕ | ✓ | ✓ | ✓ | ✕ | ✓ |
| F-score | — / 3 | 6 / 9 | 3 / 9 | 5 / 8 | 6 / 8 | 6 / 8 | 6 / 8 |
| Accruals ratio | −11.5% | −8.1% | −4.0% | 1.7% | −5.9% | −1.4% | 4.7% |
| Altman Z'' | 0.03 | 7.83 | 5.71 | 5.59 | −2.78 | −1.42 | −0.68 |
7 years of figures
Amounts in USD. Hover a ratio’s name for its definition.
| Fiscal year | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | $41.4M | $62.9M | $104M | $143M | $181M | $217M | $243M |
| Gross profit | $33.1M | $51.4M | $83.5M | $115M | $146M | $176M | $195M |
| Research and development | $9.4M | $13.4M | $20.4M | $24.8M | $35.5M | $43.9M | $50.1M |
| Operating income | −$9.8M | −$7.6M | −$13.4M | $4.2M | −$3.7M | $21.3M | $23.2M |
| Pretax income | −$11.3M | −$7.7M | −$13.4M | $7.8M | $4.8M | $23.7M | $24.4M |
| Income tax | $0.6M | $0.3M | $0.2M | $0.8M | $2.0M | −$3.0M | −$13.1M |
| Net income | −$11.9M | −$8.0M | −$13.6M | $7.0M | $2.8M | $26.7M | $37.5M |
| Diluted EPS | −$0.49 | −$0.28 | −$0.41 | $0.21 | $0.08 | $0.86 | $1.28 |
| Diluted shares | 0.02B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B |
| Cash flow | |||||||
| Cash from operations | −$4.6M | $4.8M | −$3.3M | $2.3M | $16.0M | $29.2M | $28.2M |
| Capital expenditure | $0.4M | $1.1M | $1.1M | $1.1M | $0.6M | $1.2M | $1.0M |
| Free cash flow | −$4.9M | $3.7M | −$4.4M | $1.2M | $15.3M | $28.0M | $27.2M |
| Depreciation and amortization | $0.7M | $1.2M | $2.0M | $2.3M | $3.1M | $3.4M | $3.2M |
| Stock-based compensation | $0.7M | $1.6M | $2.3M | $4.7M | $6.0M | $7.3M | $6.0M |
| Acquisitions | $0.0M | $2.5M | $0.0M | $1.1M | $8.7M | $0.0M | — |
| Balance sheet | |||||||
| Cash and short-term investments | $46.3M | $220M | $215M | $216M | $72.0M | $92.5M | $74.0M |
| Total debt | $0.0M | $0.0M | $0.0M | — | — | — | — |
| Current assets | $58.9M | $240M | $252M | $264M | $127M | $154M | $152M |
| Current liabilities | $28.5M | $45.7M | $69.3M | $84.4M | $101M | $129M | $124M |
| Property and equipment, net | $1.5M | $2.3M | $2.6M | $2.6M | $2.1M | $2.0M | $2.0M |
| Goodwill | $0.0M | $5.6M | $5.3M | $6.0M | $14.3M | $13.9M | $14.5M |
| Intangible assets | $0.0M | $2.1M | $1.6M | $1.2M | $2.4M | $1.7M | $1.0M |
| Total assets | $63.9M | $254M | $268M | $284M | $158M | $191M | $207M |
| Total liabilities | $32.5M | $53.9M | $77.6M | $91.5M | $108M | $133M | $133M |
| Shareholders' equity | $31.4M | $200M | $191M | $192M | $50.7M | $57.8M | $74.1M |
| Margins | |||||||
| Gross margin | 79.8% | 81.7% | 80.1% | 80.3% | 80.9% | 81.0% | 80.3% |
| Operating margin | −23.7% | −12.1% | −12.9% | 2.9% | −2.1% | 9.8% | 9.6% |
| EBITDA margin | −22.0% | −10.2% | −11.0% | 4.6% | −0.3% | 11.4% | 10.9% |
| Net margin | −28.7% | −12.7% | −13.0% | 4.9% | 1.6% | 12.3% | 15.5% |
| FCF margin | −11.9% | 5.9% | −4.2% | 0.8% | 8.5% | 12.9% | 11.2% |
| Returns | |||||||
| Return on capital employed | −27.8% | −3.7% | −6.8% | 2.1% | −6.4% | 34.3% | 28.0% |
| Return on equity | −38.0% | −6.9% | −7.0% | 3.7% | 2.3% | 49.3% | 56.9% |
| Return on assets | −18.7% | −5.0% | −5.2% | 2.5% | 1.3% | 15.3% | 18.9% |
| Return on tangible equity | −38.0% | −4.2% | −7.4% | 3.8% | 8.3% | 63.3% | 64.1% |
| Growth | |||||||
| Revenue growth | — | 51.8% | 65.7% | 37.1% | 26.5% | 20.0% | 11.9% |
| Net income growth | — | — | — | — | −59.5% | 841.4% | 40.3% |
| EPS growth | — | — | — | — | −61.9% | 975.0% | 48.8% |
| FCF growth | — | — | −218.6% | — | 1,170.0% | 82.7% | −2.9% |
| Share count change | — | 18.8% | 13.6% | 3.6% | −1.1% | −8.0% | −5.2% |
| Financial health | |||||||
| Debt / equity | 0.0x | 0.0x | 0.0x | — | — | — | — |
| Current ratio | 2.1x | 5.2x | 3.6x | 3.1x | 1.3x | 1.2x | 1.2x |
| Quick ratio | 2.1x | 5.2x | 3.6x | 3.1x | 1.3x | 1.2x | 1.2x |
| Capital allocation | |||||||
| Capex / revenue | 0.9% | 1.7% | 1.1% | 0.8% | 0.4% | 0.6% | 0.4% |
| Stock comp / revenue | 1.6% | 2.6% | 2.2% | 3.3% | 3.3% | 3.4% | 2.5% |
| Quality scores | |||||||
| Piotroski F-score | — | 6.0 | 3.0 | 5.0 | 6.0 | 6.0 | 6.0 |
| Altman Z'' | 0.0 | 7.8 | 5.7 | 5.6 | −2.8 | −1.4 | −0.7 |
| Accruals ratio | −11.5% | −8.1% | −4.0% | 1.7% | −5.9% | −1.4% | 4.7% |
Source: SEC EDGAR XBRL filings (CIK 0001829959). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.
